Pharma Pulse 11/20/24: Impact of ALZ on Heath Equity, Seasonal Flu Returns to Pre-Pandemic Levels, & More
The latest news for pharma industry insiders.
The Impact of Alzheimer’s Disease Treatments on Health Equity
Could health system changes that improve patient access to medication have a positive effect on societal welfare?
Spread of Seasonal Flu Returns to Pre-Pandemic Levels After End of COVID-19 Global Emergency
Increased global capacity for surveillance could help monitor seasonal influenza to reduce the risk of vaccine mismatch and inform effective interventions.
Trump Wants RFK Jr. to ‘Go Wild’ on Healthcare. Investors Need Not Panic
The vaccine skeptic may find it hard to enact sweeping changes to American healthcare.
National Ataxia Foundation Hosts Congressional Briefing with Bill Nye, The Science Guy
The National Ataxia Foundation (NAF) partnered with members of Congress to host an informational meeting for legislators, their staff and other interested parties to provide education regarding Spinocerebellar Ataxia (SCA), a group of rare and debilitating hereditary neurodegenerative diseases that frequently impact multiple family members at the same time, with no cure or FDA-approved treatment.
EVERSANA on LinkedIn
Expanding Horizons! Last month, we announced the opening of our new office in Berlin, marking a significant step in our European expansion. As Mike Ryan explains in this interview with Pharmaceutical Executive, this move strengthens our ability to navigate diverse regulatory landscapes and deliver tailored solutions to meet local healthcare needs.
#GlobalExpansion #Pharmaceuticals #Berlin
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
